Journal
/
Neuroscience
/
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
JoVE Journal
Neuroscience
Author Produced
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Neuroscience
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

English

Automatically Generated

3,939 Views

•

08:40 min

•

February 28, 2021

DOI:

10.3791/62094-v

DOI:
10.3791/62094-v

•

08:40 min
February 28, 2021

•

6 Views
, , , , ,
1Laboratory of Nuclear Medicine (LIM-43), Departamento de Radiologia e Oncologia, Faculdade de Medicina,Universidade de Sao Paulo, 2Nuclear Medicine Division,Hospital Sirio-Libanes

Summary

Automatically generated

This protocol has the aim of monitoring in vivo myelin changes (demyelination and remyelination) by positron emission tomography (PET) imaging in an animal model of multiple sclerosis.

Explore More Videos

Positron Emission TomographyPET ImagingMyelinLysolecithinMultiple SclerosisRat ModelStereotactic InjectionPIB TracerPET ScanIn Vivo ImagingTracer Injection

Read Article

Cite this Article

de Paula Faria, D., Real, C. C., Estessi de Souza, L., Teles Garcez, A., Navarro Marques, F. L., Buchpiguel, C. A. Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis. J. Vis. Exp. (168), e62094, doi:10.3791/62094 (2021).

Download .ris file

Copy

Share Video

.

Copy